Demo name of this product

Proven to increase the chances of conception

The Clearblue Fertility Monitor is the most advanced home fertility monitor providing the daily fertility status to a woman. Its innovative design incorporates a unique dual hormone assay for luteinising hormone (LH) and a urinary estrogen metabolite (estrone-3-glucuronide, E3G). It is this dual assay which enables the Clearblue Fertility Monitor to accurately assess a woman's fertility and identify more fertile days, typically giving 2 days of peak fertility and typically up to 1-5 days of high fertility per cycle prior to a woman's peak fertility. This information has been proven to increase the chances of conception by 89% in the first 2 cycles of use1. This can help to reduce the time it takes to conceive2,3 as it allows women to target intercourse to their entire fertile window, not just the two peak days.

Model of a Clearblue Fertility Monitor Cycle

The Clearblue Fertility Monitor presents the users' daily fertility status via an LCD display which clearly communicates low, high and peak fertility days to the user. The Clearblue Fertility Monitor stores information for up to six cycles and can request tests based on cycle history to ensure that women are testing on the correct days of the cycle. The Clearblue Fertility Monitor can use 10 or 20 tests per cycle, and is suitable for women with typical cycle lengths from 21-42 days.

The Clearblue Fertility Monitor is:

1 SPD data on file. When compared to a laboratory reference method, Clearblue Fertility Monitor has been shown to be 99% accurate in detecting the LH surge in 185 menstrual cycles from women of reproductive age. Reference method used: Biodata SpA LH MAIAClone Immunoradiometric Assay.
2 Robinson JE, Wakelin, Ellis JE. Increased pregnancy rate with use of the Clearblue Easy Fertility Monitor. Fertil Steril 2007 87:329‐334. 3 Robinson JE and Ellis JE. Mistiming of intercourse as a primary cause of failure to conceive: results of a survey on use of a home-use fertility monitor. Curr Med Res Opin 2007;23(2):301-6.

Copyright © 2013 SPD Swiss Precision Diagnostics GmbH. All rights reserved. Privacy Policy